Dependence of P2-nucleotide receptor agonist-mediated endothelium-independent relaxation on ectonucleotidase activity and A(2A)-receptors in rat portal vein

British Journal of Pharmacology

Volumn 123, Issue 8, 1998, Pages 1732-1740

  Guibert, Christelle ^a,c   Loirand, Gervaise ^a   Vigne, Paul ^a   Savineau, Jean Pierre ^b   Pacaud, Pierre ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

A(2A) receptors; Ecto ATPases; P2 purinoceptors; Smooth muscle

Indexed keywords

2 CHLOROADENOSINE 5' TRIPHOSPHATE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; EDETIC ACID; NUCLEOTIDASE; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL 5 PHOSPHATE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; HYDROLYSIS; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VEIN DILATATION;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; ENDOTHELIUM, VASCULAR; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; PORTAL VEIN; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2;

EID: 0031942825     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701773     Document Type: Article

References (28)

1. CHARLTON, S.J., BROWN, C.A., WEISMAN, G.A., TURNER, J.T., ERB, L. & BOARDER, M.R. (1996). PPADS and suramin as antagonists at cloned P2Y-and P2U-purinoceptors, Br. J. Pharmacol., 118, 704-710.
2. 6 glioma cells and RAW 264.7 macrophages. Br. J. Pharmacol., 119, 1628-1634.
3. 2 purinoceptor agonists, ATPγS, αβ-methylene-ATP, and AMP-PNP, in endothelial cells. Biochem. Biophys. Res. Commun., 233, 442-446.
4. CORR, L. & BURNSTOCK, G. (1994). Analysis of P2-purinoceptor subtypes on the smooth muscle and endothelium of rabbit coronary artery. J. Cardiovasc. Pharmacol., 23, 709-715.
5. 2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. (Cell Physiol.), 265, C577-C606.
6. HORIUTI, K. (1988). Mechanism of contracture on cooling of caffeine-treated frog skeletal muscle fibres. J. Physiol., 398, 131-148.
7. 2X purinoceptors be classified pharmacologically? Trends Pharmacol. Sci., 16, 168-174.
8. KENNEDY, C., TODOROV, L.D., MIHAYLOVA-TODOROVA, S. & SNEDDON, P. (1997). Release of soluble nucleotidases: a novel mechanism for neurotransmitter inactivation? Trends Pharmacol. Sci., 18, 263-266.
9. KIRLEY, T.L. (1997). Complementary DNA cloning and sequencing of the chicken muscle ecto-ATPase. J. Biol. Chem., 272, 1076-1081.
10. LAMBRECHT, G. (1996). Design and pharmacology of selective P2-purinoceptor antagonists. J. Auton. Pharmacol., 16, 341-344.
11. NORTH, R.A. & BARNARD, E.A. (1997). Nucleotide receptors. Curr. Opin. Neurobiol., 7, 346-357.
12. 2+ concentration in rat ileal myocytes. Br. J. Pharmacol., 118, 2213-2219.
13. 2+ entry. Br. J. Pharmacol., 113, 457-462.
14. 2-receptor subtypes in freshly isolated and cultured aortic myocytes. Am. J. Physiol., 269, H30-H36.
15. PIROTTON, C., COMMUNI, D., MOTTE, S., JANSSENS, R. & BOEYNAEMS, J.M. (1996). Endothelial P2-purinoceptors: subtypes and signal transduction. J. Auton. Pharmacol., 16, 353-356.
16. PIROTTON, S. & BOEYNAEMS, J.M. (1993). Evidence that ATP, ADP and AMP are not ligands of the striatal adenosine A2A receptors. Eur. J. Pharmacol., 241, 55-61.
17. PLESNER, L. (1995). Ecto-ATPases: identities and functions. Int. Rev. Cytol., 158, 141-214.
18. 2a selective adenosine receptor antagonist. Br. J. Pharmacol., 115, 1096-1102.
19. RAVELIC, V. & BURNSTOCK, G. (1991). Roles of P2-purinoceptors in the cardiovascular system. Circulation, 84, 1-14.
20. RAVELIC, V. & BURNSTOCK, G. (1996). Discrimination by PPADS between endothelial P2Y-and P2U-purinoceptors in the rat isolated mesenteric arterial bed. Br. J. Pharmacol., 118, 428-434.
21. REILLY, W.M. & BURNSTOCK, G. (1987). The effect of ATP analogues on the spontaneous electrical and mechanical activity of portal vein longitudinal muscle. Eur. J. Pharmacol., 138, 319-325.
22. TODOROV, L.D., MIHAYLOVA-TODOROVA, S., WESTFALL, T.D., SNEDDON, P., KENNEDY, C., BJUR, R.A. & WESTFALL, D.P. (1997). Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature, 387, 76-79.
23. TUCKER, A.L. & LINDEN, J. (1993). Cloned receptors and cardiovascular responses to adenosine. Cardiovasc. Res., 27, 62-67.
24. WESTFALL, T.D., KENNEDY, C. & SNEDDON, P. (1996). Enhancement of sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156. Br. J. Pharmacol., 117, 867-872.
25. WESTFALL, T.D., KENNEDY, C. & SNEDDON, P. (1997). The ecto-ATPase inhibitor ARL 67156 enhances parasympathetic neurotransmission in the guinea-pig urinary bladder. Eur. J. Pharmacol., 329, 169-173.
26. YAGI, K., SHINBO, M., HASHIZUME, M., SHIMBA, L.S., KURIMURA, S. & MIURA, Y. (1991). ATP diphosphohydrolase is responsible for ecto-ATPase and ecto-ADPase activities in bovine aorta endothelial and smooth muscle cells. Biochem. Biophys. Res. Commun., 180, 1200-1206.
27. ZIGANSHIN, A.U., HOYLE, C.H.V. & BURNSTOCK, G. (1994). Ecto-enzymes and metabolism of extracellular ATP. Drug Dev. Res., 32, 134-146.
28. ZIGANSHIN, A.U., ZIGANSHINA, L.E., KING, B.F., PINTOR, J. & BURNSTOCK, G. (1996). Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of Xenopus lacvis. Biochem. Pharmacol., 51, 897-901.